K

Kiniksa Pharmaceuticals Ltd
D

KNSA

40.370
USD
0.19
(0.48%)
مغلق
حجم التداول
13,822
الربح لكل سهم
1
العائد الربحي
-
P/E
90
حجم السوق
3,059,874,791
أصول ذات صلة الأخبار المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.